Advertisement
Advertisement
CRSP
CRISPR Therapeutics AG
55.76
USDSponsored
-3.27
-5.54%
Sep 23, 16:00 UTC -4
Closed
After-Market
56.17
+0.41
+0.74%
CRISPR Therapeutics AG Financial Snapshot
| Market Cap | 5.43B |
| Beta | 1.76 |
| Earnings Per Share (EPS) | -4.76 |
| Price-to-Book (P/B) Ratio | 3.22 |
| Operating Margin | -3368.72% |
| Total Debt/Equity (D/E) | 33.56% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -24.39% |
| Current Ratio | 17.85% |
| Free Cash Flow | -193.55M |
